Adriamycin (ADM) 24 h infusion: a phase I trial. - Speyer,J.; Bottino,J.; Nidus,B.; Blum,R.; Wernz,JC.; Levin,M.; Hymes,K.; Muggia,FM. (Proc Am Assoc Cancer Res and ASCO, 1981)